Virus‐like particles induce robust human T‐helper cell responses

Among synthetic vaccines, virus‐like particles (VLPs) are used for their ability to induce strong humoral responses. Very little is reported on VLP‐based‐vaccine‐induced CD4+ T‐cell responses, despite the requirement of helper T cells for antibody isotype switching. Further knowledge on helper T cells is also needed for optimization of CD8+ T‐cell vaccination. Here, we analysed human CD4+ T‐cell responses to vaccination with MelQbG10, which is a Qβ‐VLP covalently linked to a long peptide derived from the melanoma self‐antigen Melan‐A. In all analysed patients, we found strong antibody responses of mainly IgG1 and IgG3 isotypes, and concomitant Th1‐biased CD4+ T‐cell responses specific for Qβ. Although less strong, comparable B‐ and CD4+ T‐cell responses were also found specific for the Melan‐A cargo peptide. Further optimization is required to shift the response more towards the cargo peptide. Nevertheless, the data demonstrate the high potential of VLPs for inducing humoral and cellular immune responses by mounting powerful CD4+ T‐cell help.

[1]  S. Crotty,et al.  Follicular helper CD4 T cells (TFH). , 2011, Annual review of immunology.

[2]  Martin F. Bachmann,et al.  Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns , 2010, Nature Reviews Immunology.

[3]  L. Sherman,et al.  CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes. , 2010, Cancer research.

[4]  R. Dummer,et al.  Memory and Effector CD8 T-cell Responses After Nanoparticle Vaccination of Melanoma Patients , 2010, Journal of immunotherapy.

[5]  D. Speiser,et al.  Tumor antigen-specific FOXP3+ CD4 T cells identified in human metastatic melanoma: peptide vaccination results in selective expansion of Th1-like counterparts. , 2009, Cancer research.

[6]  F. Sallusto,et al.  Heterogeneity of CD4+ memory T cells: Functional modules for tailored immunity , 2009, European journal of immunology.

[7]  Martin F. Bachmann,et al.  The coming of age of virus-like particle vaccines , 2008, Biological chemistry.

[8]  S. Vogel,et al.  Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming , 2007, Proceedings of the National Academy of Sciences.

[9]  R. Germain,et al.  Chemokine-Guided CD4+ T Cell Help Enhances Generation of IL-6RαhighIL-7Rαhigh Prememory CD8+ T Cells1 , 2007, The Journal of Immunology.

[10]  Katharina Fleischhauer,et al.  Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans , 2006, Immunological reviews.

[11]  T. Kündig,et al.  Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults. , 2006, The Journal of allergy and clinical immunology.

[12]  Grégoire Altan-Bonnet,et al.  Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell–dendritic cell interaction , 2006, Nature.

[13]  E John Wherry,et al.  Generation and maintenance of immunological memory. , 2004, Seminars in immunology.

[14]  Hao Shen,et al.  Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory , 2003, Science.

[15]  Urs Christen,et al.  CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes , 2003, Nature.

[16]  E. V. van Donselaar,et al.  The Melanocytic Protein Melan‐A/MART‐1 Has a Subcellular Localization Distinct from Typical Melanosomal Proteins , 2002, Traffic.

[17]  A. Jegerlehner,et al.  A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses. , 2002, Vaccine.

[18]  D. Lowy,et al.  Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies. , 2001, The Journal of clinical investigation.

[19]  C. Snapper,et al.  B‐cell activation by T‐cell‐independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms , 2000, Immunological reviews.

[20]  I. Frazer,et al.  HPV6b virus like particles are potent immunogens without adjuvant in man. , 2000, Vaccine.

[21]  Richard A. Flavell,et al.  Help for cytotoxic-T-cell responses is mediated by CD40 signalling , 1998, Nature.

[22]  J. Berzofsky,et al.  Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL , 1996, The Journal of experimental medicine.

[23]  F. Podlaski,et al.  Interleukin‐12 profoundly up‐regulates the synthesis of antigen‐specific complement‐fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo , 1995, European journal of immunology.

[24]  J. Yata,et al.  Regulation of human IgG subclass production by cytokines. IFN-gamma and IL-6 act antagonistically in the induction of human IgG1 but additively in the induction of IgG2. , 1994, Journal of immunology.

[25]  R. Zinkernagel,et al.  The influence of antigen organization on B cell responsiveness. , 1993, Science.

[26]  P. Matzinger,et al.  A fail-safe mechanism for maintaining self-tolerance , 1992, The Journal of experimental medicine.

[27]  L. Husmann,et al.  Cooperation between Helper T Cells and Cytotoxic T Lymphocyte Precursors , 1988, Annals of the New York Academy of Sciences.

[28]  T. Honjo,et al.  Immunoglobulin class switching , 1984, Cell.

[29]  R. Aalberse,et al.  Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. , 1983, Journal of immunology.

[30]  J. Forman,et al.  Helper activity is required for the in vivo generation of cytotoxic T lymphocytes , 1982, The Journal of experimental medicine.

[31]  B. Vogelstein,et al.  Specific cellular stimulation in the primary immune response: experimental test of a quantized model. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[32]  P. Chattopadhyay,et al.  Live-cell assay to detect antigen-specific CD4+ T-cell responses by CD154 expression , 2006, Nature Protocols.

[33]  F. Skvaril.  IgG subclasses in viral infections. , 1986, Monographs in allergy.